27890-92-2

Usage

Uses

Used in Pharmaceutical Industry:
4-(2-Methoxy-ethoxy)-benzoic acid is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs. Its chemical structure allows it to be a versatile building block in medicinal chemistry.
Used in Dye Industry:
In the dye industry, 4-(2-Methoxy-ethoxy)-benzoic acid is utilized as an intermediate in the production of dyes, where its chemical properties contribute to the creation of colorants with specific characteristics.
Used in Polymer and Plastics Industry:
4-(2-Methoxy-ethoxy)-benzoic acid serves as a stabilizer in the manufacturing process of polymers and plastics, enhancing the stability and performance of these materials.
Used in Medical Research and Drug Development:
Due to its structure and properties, 4-(2-Methoxy-ethoxy)-benzoic acid may have potential applications in medical research and drug development, where it could be explored for its possible role in creating new therapeutic agents or improving existing ones.

InChI:InChI=1/C10H12O4/c1-13-6-7-14-9-4-2-8(3-5-9)10(11)12/h2-5H,6-7H2,1H3,(H,11,12)

Upstream product

• 6482-24-2 2-Bromoethyl methyl ether 
• 99-96-7 4-hydroxy-benzoic acid 
• 60893-68-7 methyl 4-(2-methoxyethoxy)benzoate 
• 99-76-3 methyl 4-hydroxylbenzoate 

Downstream Products

• 1429526-44-2 4-{(1E)-3-[(6-chlorohexyl)oxy]-3-oxoprop-1-enyl}phenyl 4-(2-methoxyethoxy)benzoate 
• 1429526-45-3 6-{[(2E)-3-(4-{[4-(2-methoxyethoxy)benzoyl]oxy}phenyl)prop-2-enoyl]oxy}hexyl 3,5-dinitrobenzoate 
• 1444124-33-7 C₁₆H₂₆N₂O₅ 
• 1400701-28-1 4-(2-methoxyethoxy)benzyl 4-methylbenzenesulfonate 
• 79407-30-0 [4-(2-methoxyethoxy)phenyl]methanol 
• 27890-91-1 C₂₇H₃₈N₂O₆ 

Relevant academic research and scientific papers

ORGANIC COLORANT, COLORING COMPOSITION, AND INKJET INK

Organic colorant represented by General Formula (1) below: where in the General Formula (1), R1 and R2 each independently represent C1-C20 alkyl group, C1-C20 alkenyl group, phenyl group, naphthyl group, or group represented by —(CH

COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS

The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a Respiratory Syncytial Virus (RSV) infection, wherein treatment comprises administering a compound effective to inhibit the function of the RSV and an additional compound or combinations of compounds having anti-RSV activity.

C-3 NOVEL TRITERPENONE WITH C-17 REVERSE AMIDE DERIVATIVES AS HIV INHIBITORS

The present invention relates to C-3 novel triterpenone with C-17 reverse amide compounds of Formula (I); and pharmaceutically acceptable salts thereof, wherein ring Formula (II), R1, R2, R3, R4, R5, R6, R7, 'n' and 'm' are as defined in Formula (I). The invention also relates to C-3 novel triterpenone with C-17 reverse amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.

COMPOUNDS FOR MODULATING AQUAPORINS

The invention relates to compounds of formula (I) pharmaceutical compositions thereof and methods for modulating aquaporin 9.

BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS

The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

PHOTOALIGNING MATERIALS

The present invention relates to polymer, homo- or copolymer or oligomer for the photoalignment of liquid crystals, especially for the planar orientation of liquid crystals, comprising a main chain and a side chain, wherein the side chain and/or main chain comprises a polar group, compositions thereof, and its use for optical and electro optical devices, especially liquid crystal devices (LCDs).

PHOTOALIGNING MATERIALS

The present invention relates to polymer, homo- or copolymer or oligomer, which, when irradiated with polarised light orients perpendicular to the polarization direction of polarized actinic light, for the photoalignment of liquid crystals, especially for the planar orientation of liquid crystals, and which derives from at least one monomer (I), compositions thereof, and its use for optical and electro optical devices, such as, liquid crystal devices (LCDs), especially for planar orientation of liquid crystals.

N,N'-Heptamethylenebis(4-methoxybenzamide)

4-(Q-O)-4'-R1 -N,N'-alkylenebis(benzamides), N,N'-alkylenebis(3,4-methylenedioxybenzamides) or N,N'-alkylenebis[4-(lower-alkoxy)benzamides], having endocrinological properties, where Q is lower-alkyl, lower-alkoxyalkyl, lower-alkenyl, halo-lower-alkyl, halo-lower-alkenyl, lower-cycloalkyl, phenyl and BN-(lower-alkyl) where BN is di-(lower-alkyl)amino or a saturated N-heteromonocyclic radical having from five to seven ring atoms and alkylene has at least five carbon atoms between its two connecting linkages and R1 is Q-O-, hydrogen, lower-alkoxy, lower-alkyl, halo, benzyloxy, hydroxy, di-(lower-alkyl)amino, nitro, amino or trihalomethyl are prepared preferably by reacting the appropriate diamine or N-(aminoalkyl)-benzamide with two or one molar equivalents, respectively, of the appropriate benzoyl halide.